Prostate Adenocarcinoma — Trials

Prostate Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

433 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 62
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (71)

clinicaltrialsPublishedShowing 101–146 of 146 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07285057	Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance	recruiting	Phase 2	120	Icahn School of Medicine at Mount SinaiOTHER	1	Feb 23, 2026	clinicaltrials
NCT05683964	Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression	active not recruiting	Early Phase 1	9	Beth Israel Deaconess Medical CenterOTHER	1	Feb 13, 2026	clinicaltrials